The Function of Biphasic Sleep in Infants

Last updated: May 6, 2024
Sponsor: University of Massachusetts, Amherst
Overall Status: Active - Recruiting

Phase

N/A

Condition

Insomnia

Sleep Disorders

Treatment

Wake

Nap

Clinical Study ID

NCT06399939
4320
  • Ages 9-15
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study is designed to investigate developmental changes in naps and nap function on memory from 9 to 15 months of age. Memory is measured by a task in which the experimenter interacts with a toy and the measure of memory is whether the child imitates that action when given the toy. Sleep is assessed with a watch that detects motion which provides an estimate of sleep and a set of electrodes placed on the head that measures brain activity during sleep. Infants are recruited at 9 months and sleep and memory are measured again 3- and 6-months later. At each visit, memory is tested before and after a nap (either the morning or afternoon nap) and naps are recorded with the sleep electrodes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. 9 months at the time of enrollment
  2. normal birthweight (5.5 to 10 lbs) and gestational length (36-41 weeks)
  3. must be willing and able to return for testing in 3 and 6 months (e.g., no plans tomove out of the area)

Exclusion

Exclusion Criteria:

  1. born premature (<36 weeks gestational age)
  2. receiving services due to developmental delays
  3. visual or motor disability
  4. score <85 on cognitive and language composite scales and/or <80 on the average of thetwo composites of the Bayley Scales of Infant Development Fourth Edition (BSID-IV)administered at the first session.
  5. Infants' motor development (gross and fine motor) will also be assessed using theBSID-IV, and an adjusted cutoff of 73 will be used to exclude infants with significantmotor delays (given the motoric nature of the task).
  6. traveling beyond 1 time zone within 2 weeks prior to testing (phone screening)
  7. fever or symptoms of respiratory illness at the time of testing (phone screening)
  8. physical handicap that interferes with assessments (vision, hearing impairment; phonescreening)
  9. history of neurological injury such as history of seizures, brain tumor, or stroke (phone screening) Parents/guardians of potential participants will be contacted viaphone and/or email, at which time the details of the study will be specified andinclusion/exclusion criteria will be reviewed.

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Wake
Phase:
Study Start date:
September 01, 2023
Estimated Completion Date:
January 31, 2029

Study Description

Four days prior to the first session, an experimenter will meet the caregiver and infant (at the lab or at their home) to review procedures and complete the informed consent process. The infant will be fitted with the actigraph watch on the ankle. The caregiver will be given instructions on use of the actigraph watch and be left with questionnaires to complete (e.g., sleep diary, behavioral questionnaires). Four days later, the caregiver and infant will come to the sleep lab for their initial session. In wave 1 (9 months), caregiver-infant dyads will be scheduled to arrive ~1 hr prior to the infant's typical morning nap time. In later waves, if the infant is reported to have eliminated their morning nap, they will be scheduled to arrive ~1 hr prior to when the nap typically occurred before they transitioned out of the morning nap. Infants will be semi-randomly assigned to either the nap or wake condition. Following acclimation to the lab, the infant will be fitted with the polysomnography (electrode) cap. The infant will then complete the encoding and immediate recall phases of the deferred imitation (memory) task. The infant will then be either wake or nap promoted or allowed to follow their normal morning routine. Approximately 90 mins later (following nap waking and time to recover from sleep inertia), the deferred imitation task (recall) will take place.

The caregiver and infant will then have free time (lunch, playtime), with instructions to return to the lab (if they choose to leave; they are also offered access to the lab kitchen and lounge area) ~40 mins before the infant's typical afternoon nap. They will also be instructed to: (1) avoid letting the infant nap and report any sleep that occurred (this will also be monitored with actigraphy); (2) not partake in any unusually stimulating activities; and (3) to follow a routine feeding schedule during this time. When the dyad returns to the lab, the infant will again be equipped with the polysomnography cap and complete the encoding and immediate recall phases with a new set of items. The infant will then either be wake or nap promoted or allowed to follow their normal afternoon nap routine. Approximately 90 mins later (following nap and time to recover from sleep inertia), the delayed recall phase will take place. The infant and caregiver will return to the lab one week later to complete the other condition. The procedures will be repeated at 12 (>12 months and <13 months) and 15 months (>15 months and <16 months).

Connect with a study center

  • University of Massachusetts, Amherst

    Amherst, Massachusetts 01003
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.